Cargando…

Fatty acid binding protein 5 regulates docetaxel sensitivity in taxane-resistant prostate cancer cells

Prostate cancer is a leading cause of cancer-related deaths in men in the United States. Although treatable when detected early, prostate cancer commonly transitions to an aggressive castration-resistant metastatic state. While taxane chemotherapeutics such as docetaxel are mainstay treatment option...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hillowe, Andrew, Gordon, Chris, Wang, Liqun, Rizzo, Robert C., Trotman, Lloyd C., Ojima, Iwao, Bialkowska, Agnieszka, Kaczocha, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553314/ https://www.ncbi.nlm.nih.gov/pubmed/37796964 http://dx.doi.org/10.1371/journal.pone.0292483

Ejemplares similares

Fatty acid binding proteins are novel modulators of synaptic epoxyeicosatrienoic acid signaling in the brain
por: Glaser, Sherrye T., et al.
Publicado: (2023)

Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia
por: Kaczocha, Martin, et al.
Publicado: (2014)

Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs
por: Berger, William T., et al.
Publicado: (2012)

Docetaxel: an alternative taxane in ovarian cancer
por: Katsumata, N
Publicado: (2003)

Glutathione S-transferases (GSTs) polymorphism and taxane (docetaxel) sensitivity in breast cancer
por: Lee, Anbok
Publicado: (2019)

Identification of Fatty Acid Binding Protein 5 Inhibitors Through Similarity-Based Screening
por: Zhou, Yuchen, et al.
Publicado: (2019)

Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms
por: Peng, Xiaoxue, et al.
Publicado: (2017)

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis
por: Al Nakouzi, Nader, et al.
Publicado: (2016)

Caspase-2 is involved in cell death induction by taxanes in breast cancer cells
por: Jelínek, Michael, et al.
Publicado: (2013)

The role of individual caspases in cell death induction by taxanes in breast cancer cells
por: Jelínek, Michael, et al.
Publicado: (2015)

SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells
por: Zheng, Xiaowei, et al.
Publicado: (2017)

SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells
por: Zheng, Xiaowei, et al.
Publicado: (2022)

SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells
por: Zheng, Xiaowei, et al.
Publicado: (2023)

Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes
por: Grayson, Korie A., et al.
Publicado: (2021)

Registered report: androgen receptor splice variants determine taxane sensitivity in prostate cancer
por: Shan, Xiaochuan, et al.
Publicado: (2015)

Replication study: androgen receptor splice variants determine taxane sensitivity in prostate cancer
por: Shan, Xiaochuan, et al.
Publicado: (2018)

SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
por: Zielske, Steven P., et al.
Publicado: (2023)

Enhanced anti-tumor efficacy and mechanisms associated with docetaxel-piperine combination- in vitro and in vivo investigation using a taxane-resistant prostate cancer model
por: Li, Chenrui, et al.
Publicado: (2017)

Co-Targeting ErbB Receptors and the PI3K/AKT Axis in Androgen-Independent Taxane-Sensitive and Taxane-Resistant Human Prostate Cancer Cells
por: Adediran, Samusi, et al.
Publicado: (2022)

Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes
por: Ríos-Colón, Leslimar, et al.
Publicado: (2017)

Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells
por: Cristofani, Riccardo, et al.
Publicado: (2018)

Prostate Cancer Stem Cell-Targeted Efficacy of a New-Generation Taxoid, SBT-1214 and Novel Polyenolic Zinc-Binding Curcuminoid, CMC2.24
por: Botchkina, Galina I., et al.
Publicado: (2013)

Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells
por: Wang, Harris, et al.
Publicado: (2014)

Incarvillateine produces antinociceptive and motor suppressive effects via adenosine receptor activation
por: Kim, Jinwoo, et al.
Publicado: (2019)

Mutations in BRCA2 and taxane resistance in prostate cancer
por: Nientiedt, Cathleen, et al.
Publicado: (2017)

The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes
por: Seborova, Karolina, et al.
Publicado: (2021)

The Prostate Cancer Cells Resistant to Docetaxel as in vitro Model for Discovering MicroRNAs Predictive of the Onset of Docetaxel Resistance
por: Bascetta, Lorenzo, et al.
Publicado: (2017)

Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel
por: Luty, Marcin, et al.
Publicado: (2019)

Docetaxel Treatment for Metastatic Hormone-sensitive Prostate Cancer in Daily Practice
por: de Groot, Ietsen, et al.
Publicado: (2021)

Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
por: Martellucci, Stefano, et al.
Publicado: (2021)

Effectiveness of Docetaxel for Metastatic Hormone-sensitive Prostate Cancer in Clinical Practice
por: Lendorf, Maria Elisabeth, et al.
Publicado: (2021)

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma
por: Liu, Sai-Lan, et al.
Publicado: (2018)

Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model
por: Seborova, Karolina, et al.
Publicado: (2022)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

ERG induces taxane resistance in castration-resistant prostate cancer
por: Galletti, Giuseppe, et al.
Publicado: (2014)

Competence against insufficiency: Why are men mostly safe from a rare and deadly prostate cancer?
por: Mathew, Grinu, et al.
Publicado: (2020)

Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors
por: Ferlini, C, et al.
Publicado: (2000)

Designing and Testing of Novel Taxanes to Probe the Highly Complex Mechanisms by Which Taxanes Bind to Microtubules and Cause Cytotoxicity to Cancer Cells
por: St. George, Marc, et al.
Publicado: (2015)

Fatty Acid-Binding Protein 5 Modulates Brain Endocannabinoid Tone and Retrograde Signaling in the Striatum
por: Fauzan, Mohammad, et al.
Publicado: (2022)

Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer
por: Talwar, Harkirat Singh
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lccmbrd3ffs8e85jtj7cvr2hrf